Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics

American Journal of Psychiatry

Volumn 166, Issue 1, 2009, Pages 114-115

  Ladds, Brian ^a   Thomas, Pierre ^a   Mejia, Carlina ^a   Hauser, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BROMOCRIPTINE; CLOZAPINE; CREATINE KINASE; LORAZEPAM; RISPERIDONE; VALPROIC ACID;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MYOCARDIAL INFARCTION; NEUROLEPTIC MALIGNANT SYNDROME; PIPERAZINES; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; VALPROIC ACID;

EID: 59749103977     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08101485     Document Type: Letter

References (4)

1. Pelonero AL, Levenson JL, Pandurangi AK: Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998; 49:1163-1172
2. Croarkin PE, Emslie GJ, Mayes TL: Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry 2008; 17:e1-e9
3. Sanai T, Matsui R, Hirano T, Torichigai S, Yotsueda H, Higashi H, Hirakata H, Iida M: Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic renal failure. Ren Fail 2006; 28:51-55
4. Hanft A, Eggleston CF, Bourgeois JA: Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol 2004; 14:481-487